Changhoon Ji
Executive Director, R&D Institute AUTOTAC Bio
Dr. Changhoon Ji is Executive Director of the R&D Institute at AUTOTAC Bio, where he leads research efforts advancing the company’s targeted protein degradation platform. He also serves as a Research Associate Professor at the Cellular Degradation Biology Center at Seoul National University, contributing to cutting-edge research in degradation biology and therapeutic innovation. In addition, Dr. Ji is an External Review Board Member for Korea Rating & Data (KoDATA). He earned his Ph.D. in Biomedical Science from Seoul National University and brings extensive expertise in translational biomedical research, drug discovery, and the development of next-generation therapeutics.
Seminars
Thursday 10th December 2026
Laying Out Structural Biology & Biophysical Approaches to Undergo Functional Characterization of AUTOTAC Induced Proximity Therapies
1:30 pm
- Unlocking insights from structural and biophysical and characterization to design and optimize AUTOTAC constructs that facilitate multi-protein assembly
- Describing early functional characterization of selective binding of autophagy-targeting ligand to ZZ domain of the archetypal autophagy cargo receptor p62/SQSTM1
- Laying out experimental validation from AUTOTAC discovery through ongoing preclinical and clinical-stage development of pipeline candidates
